Please login to the form below
Viagra
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Viagra was produced by Pfizer.
A snapshot of Healx
and Dr David Brown, co- inventor of Viagra and former Global Head of Drug Discovery at Roche.
Pfizer set to unveil Mylan merger and spin-off
Its biggest off-patent brands would include drugs such as Pfizer’s Lipitor, Viagra and Mylan’s Epipen.
The handover: Pfizer reshapes itself for a new era
autonomous. Created in the summer reshuffle, the Established Medicines division includes the majority of Pfizer’s off-patent blockbuster pills, including Lyrica, Lipitor, Norvasc and Viagra, and a number of other
Brand teams: why are some smarter than others?
They defeat powerful incumbents, like Cialis did with Viagra, or they overcome health-system conservatism, as Abbot is doing with its FreeStyle Libre device.
Prix Galien opens for entries with new award
Previous UK Prix Galien winners include well-known brands such as Viagra, Herceptin, Glivec, Xolair, Bexero, Cervarix and Gardasil.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Keytruda doubles five-year survival rate in NSCLC
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
